Medical Care

Global Type 2 Diabetes Therapeutics Market Research Report 2024

The Type 2 Diabetes Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 2 Diabetes Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Segment by Type
DPP-4 Inhibitors
Biguanides
Insulins
SGLT-2 Inhibitors
α-Glucosidase Inhibitors
Other
Segment by Application
Children
Middle-Aged Person
Aged
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 2 Diabetes Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DPP-4 Inhibitors
1.2.3 Biguanides
1.2.4 Insulins
1.2.5 SGLT-2 Inhibitors
1.2.6 α-Glucosidase Inhibitors
1.2.7 Other
1.3 Market by Application
1.3.1 Global Type 2 Diabetes Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Middle-Aged Person
1.3.4 Aged
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Type 2 Diabetes Therapeutics Market Perspective (2019-2030)
2.2 Type 2 Diabetes Therapeutics Growth Trends by Region
2.2.1 Global Type 2 Diabetes Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Type 2 Diabetes Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Type 2 Diabetes Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Type 2 Diabetes Therapeutics Market Dynamics
2.3.1 Type 2 Diabetes Therapeutics Industry Trends
2.3.2 Type 2 Diabetes Therapeutics Market Drivers
2.3.3 Type 2 Diabetes Therapeutics Market Challenges
2.3.4 Type 2 Diabetes Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 2 Diabetes Therapeutics Players by Revenue
3.1.1 Global Top Type 2 Diabetes Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Type 2 Diabetes Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Type 2 Diabetes Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type 2 Diabetes Therapeutics Revenue
3.4 Global Type 2 Diabetes Therapeutics Market Concentration Ratio
3.4.1 Global Type 2 Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Therapeutics Revenue in 2023
3.5 Type 2 Diabetes Therapeutics Key Players Head office and Area Served
3.6 Key Players Type 2 Diabetes Therapeutics Product Solution and Service
3.7 Date of Enter into Type 2 Diabetes Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 2 Diabetes Therapeutics Breakdown Data by Type
4.1 Global Type 2 Diabetes Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Type (2025-2030)
5 Type 2 Diabetes Therapeutics Breakdown Data by Application
5.1 Global Type 2 Diabetes Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Type 2 Diabetes Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Type 2 Diabetes Therapeutics Market Size (2019-2030)
6.2 North America Type 2 Diabetes Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Type 2 Diabetes Therapeutics Market Size by Country (2019-2024)
6.4 North America Type 2 Diabetes Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Type 2 Diabetes Therapeutics Market Size (2019-2030)
7.2 Europe Type 2 Diabetes Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Type 2 Diabetes Therapeutics Market Size by Country (2019-2024)
7.4 Europe Type 2 Diabetes Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Type 2 Diabetes Therapeutics Market Size (2019-2030)
9.2 Latin America Type 2 Diabetes Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Type 2 Diabetes Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Type 2 Diabetes Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 2 Diabetes Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Type 2 Diabetes Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Type 2 Diabetes Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Type 2 Diabetes Therapeutics Introduction
11.2.4 Novartis Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Introduction
11.4.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Type 2 Diabetes Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Type 2 Diabetes Therapeutics Introduction
11.7.4 Merck Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Type 2 Diabetes Therapeutics Introduction
11.8.4 Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2019-2024)
11.8.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DPP-4 Inhibitors
Table 3. Key Players of Biguanides
Table 4. Key Players of Insulins
Table 5. Key Players of SGLT-2 Inhibitors
Table 6. Key Players of α-Glucosidase Inhibitors
Table 7. Key Players of Other
Table 8. Global Type 2 Diabetes Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Type 2 Diabetes Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Type 2 Diabetes Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Type 2 Diabetes Therapeutics Market Share by Region (2019-2024)
Table 12. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Type 2 Diabetes Therapeutics Market Share by Region (2025-2030)
Table 14. Type 2 Diabetes Therapeutics Market Trends
Table 15. Type 2 Diabetes Therapeutics Market Drivers
Table 16. Type 2 Diabetes Therapeutics Market Challenges
Table 17. Type 2 Diabetes Therapeutics Market Restraints
Table 18. Global Type 2 Diabetes Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Type 2 Diabetes Therapeutics Market Share by Players (2019-2024)
Table 20. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Therapeutics as of 2023)
Table 21. Ranking of Global Top Type 2 Diabetes Therapeutics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Type 2 Diabetes Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Type 2 Diabetes Therapeutics Product Solution and Service
Table 25. Date of Enter into Type 2 Diabetes Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Type 2 Diabetes Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2019-2024)
Table 29. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2025-2030)
Table 31. Global Type 2 Diabetes Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Type 2 Diabetes Therapeutics Revenue Market Share by Application (2019-2024)
Table 33. Global Type 2 Diabetes Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Type 2 Diabetes Therapeutics Revenue Market Share by Application (2025-2030)
Table 35. North America Type 2 Diabetes Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Type 2 Diabetes Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Type 2 Diabetes Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Type 2 Diabetes Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Type 2 Diabetes Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Type 2 Diabetes Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Type 2 Diabetes Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Type 2 Diabetes Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Type 2 Diabetes Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Type 2 Diabetes Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Type 2 Diabetes Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Type 2 Diabetes Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Type 2 Diabetes Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 50. AstraZeneca Company Detail
Table 51. AstraZeneca Business Overview
Table 52. AstraZeneca Type 2 Diabetes Therapeutics Product
Table 53. AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 54. AstraZeneca Recent Development
Table 55. Novartis Company Detail
Table 56. Novartis Business Overview
Table 57. Novartis Type 2 Diabetes Therapeutics Product
Table 58. Novartis Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Novo Nordisk Company Detail
Table 61. Novo Nordisk Business Overview
Table 62. Novo Nordisk Type 2 Diabetes Therapeutics Product
Table 63. Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 64. Novo Nordisk Recent Development
Table 65. Boehringer Ingelheim Company Detail
Table 66. Boehringer Ingelheim Business Overview
Table 67. Boehringer Ingelheim Type 2 Diabetes Therapeutics Product
Table 68. Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 69. Boehringer Ingelheim Recent Development
Table 70. Bristol-Myers Squibb Company Detail
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product
Table 73. Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Eli Lilly Company Detail
Table 76. Eli Lilly Business Overview
Table 77. Eli Lilly Type 2 Diabetes Therapeutics Product
Table 78. Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 79. Eli Lilly Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Type 2 Diabetes Therapeutics Product
Table 83. Merck Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Type 2 Diabetes Therapeutics Product
Table 88. Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2019-2024) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 2 Diabetes Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Type 2 Diabetes Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. DPP-4 Inhibitors Features
Figure 4. Biguanides Features
Figure 5. Insulins Features
Figure 6. SGLT-2 Inhibitors Features
Figure 7. α-Glucosidase Inhibitors Features
Figure 8. Other Features
Figure 9. Global Type 2 Diabetes Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Type 2 Diabetes Therapeutics Market Share by Application: 2023 VS 2030
Figure 11. Children Case Studies
Figure 12. Middle-Aged Person Case Studies
Figure 13. Aged Case Studies
Figure 14. Type 2 Diabetes Therapeutics Report Years Considered
Figure 15. Global Type 2 Diabetes Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Type 2 Diabetes Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Type 2 Diabetes Therapeutics Market Share by Region: 2023 VS 2030
Figure 18. Global Type 2 Diabetes Therapeutics Market Share by Players in 2023
Figure 19. Global Top Type 2 Diabetes Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Therapeutics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Therapeutics Revenue in 2023
Figure 21. North America Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Type 2 Diabetes Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Type 2 Diabetes Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Type 2 Diabetes Therapeutics Market Share by Region (2019-2030)
Figure 35. China Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Type 2 Diabetes Therapeutics Market Share by Country (2019-2030)
Figure 43. Mexico Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Type 2 Diabetes Therapeutics Market Share by Country (2019-2030)
Figure 47. Turkey Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Type 2 Diabetes Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 51. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 54. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 56. Sanofi Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies